We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SHBBS:AQUISEUSvenska Handelsbanken AB Class B Analysis

Data as of 2026-03-11 - not real-time

SEK 237.40

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Svenska Handelsbanken trades at SEK 237.4, which sits exactly on the calculated support level and just below the 20‑day SMA of 237.98, indicating limited upside in the near term. The RSI of 61 suggests modest bullish momentum, but the MACD histogram is negative and the MACD line sits beneath its signal, flagging potential short‑term weakness. Volume trends are decreasing, with an average three‑month volume of only 62 shares, raising concerns about liquidity. Fundamentally, the bank’s PE ratio of 19.57 exceeds the industry average of 17.19, hinting at a modest premium valuation. Revenue has contracted by 12.2% year‑over‑year and operating cash flow is negative, which tempers the attractiveness of the current dividend yield of 3.37%. The payout ratio of 61.9% is sustainable given the substantial cash reserves, yet the high debt balance of SEK 1.6 trillion and a beta of only 0.357 underscore a low‑risk market exposure but heightened balance‑sheet risk. Volatility remains elevated at 37% over the past 30 days, and the max drawdown of just under 5% reflects a relatively contained downside. Overall, the stock presents a mixed picture: solid dividend income and a stable banking franchise counterbalanced by earnings pressure and a valuation that leans toward the higher side of its peer group.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price at technical support with bearish MACD
  • Decreasing volume and liquidity concerns
  • Negative operating cash flow

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Attractive dividend yield of 3.37%
  • Revenue contraction and earnings pressure
  • Stable banking franchise and low beta

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Solid ROE around 11.7% and strong capital base
  • Long‑term dividend sustainability despite short‑term cash flow dip
  • Valuation premium may narrow as earnings stabilize

Key Metrics & Analysis

Financial Health

Revenue Growth-12.20%
Profit Margin41.54%
P/E Ratio19.6
ROE11.72%
ROA0.69%
P/B Ratio2.4
Op. Cash FlowSEK-61110001664
Industry P/E17.2

Technical Analysis

TrendBullish
RSI61.3
SupportSEK 237.40
ResistanceSEK 249.10
MA 20SEK 237.98
MA 50SEK 230.90
MA 200SEK 204.92
MACDBearish
VolumeDecreasing
Fear & Greed Index78

Valuation

GradeOvervalued
TypeValue
Dividend Yield3.37%

Risk Assessment

Beta0.01
Volatility37.10%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.